360b / Shutterstock.com
Pharmaceutical company Bristol-Myers Squibb (BMS) has agreed a deal that gives it the option of acquiring drug maker F-star Alpha and one of its breast and gastric cancer treatments.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Bristol-Myers-Squibb, F-star Alpha, pharmaceutical patent, FS102